Spinal Elements Holdings Research and Development Expenses 1970-1969 | SPEL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Spinal Elements Holdings research and development expenses from 1970 to 1969. Research and development expenses can be defined as an expense arising from studies and product development processes.

Spinal Elements Holdings Research and Development Expenses 1970-1969 | SPEL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Spinal Elements Holdings research and development expenses from 1970 to 1969. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$185.9B
Thermo Fisher Scientific (TMO)	$156.6B
Edwards Lifesciences (EW)	$44.9B
Alcon (ALC)	$43.1B
IDEXX Laboratories (IDXX)	$41.4B
DexCom (DXCM)	$32.9B
IQVIA Holdings (IQV)	$27.8B
Mettler-Toledo (MTD)	$24.8B
STERIS (STE)	$22.2B
SONOVA HOLDING (SONVY)	$17.4B
Waters (WAT)	$17.1B
Hologic (HOLX)	$14.3B
Sysmex ADR (SSMXY)	$10.4B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.4B
Globus Medical (GMED)	$7.6B
Glaukos (GKOS)	$5.6B
Teleflex (TFX)	$4.9B
Integer Holdings (ITGR)	$3.9B
TransMedics (TMDX)	$3.7B
PROCEPT BioRobotics (PRCT)	$3.2B
LivaNova (LIVN)	$2.3B
Elekta AB (EKTAY)	$1.9B
Nihon Kohden (NHNKY)	$1.9B
Veracyte (VCYT)	$1.8B
Alphatec Holdings (ATEC)	$1.5B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$1B